scieee Science in your language
[en] (orig)
Hollow fibres integrated in a microfluidic cell culture system
C. Winkelmann1, Y. Luo2, A. Lode2, M. Gelinsky2, U. Marx3, F. Sonntag1
1Fraunhofer Institute for Material and Beam Technology IWS, Dresden, Germany;
claudia.winkelmann@iws.fraunhofer.de
2 Technische Universität Dresden, Centre for Translational Bone, Joint and Soft Tissue Research, Dresden, Germany
3 Technical University Berlin, Institute of Biotechnology, Berlin, Germany
Abstract
For in vitro drug screening a modified perfusion micro-bioreactor system with integrated hollow fibres will be demon-
strated. This biocompatible system consists of an integrated closed flow circuit that includes reservoirs and pneumatic
micro pumps. Additional optical online-monitoring devices allow the observation during the cell cultivation. The em-
bedded hollow fibre system which acts as cell carrier consists of a biodegradable biopolymer. One option to fabricate
such 3D structures is the technology of Organ Printing which is realised by an adapted rapid prototyping system entitled
3D Scaffold Printer. With this device specimens consisting of tubes with a diameter smaller than 2 mm can be prepared.
It should be possible to cultivate the hollow fibres inside and outside with different kinds of cells and therefore generate
models of complex tissues.
1 Introduction
Organ typical tissue cultures have been already established
in limited fields of regenerative medicine. Artificial skin
tissues, cartilage and bone implants could be developed
successfully in the last years. The development of such
complex three-dimensional tissue cultures is becoming
also more and more important for the pharmaceutical and
biochemical industry as a substitute for animal experi-
ments. Such an in vitro substance testing requires the as-
similative interaction of different cells or tissues within a
common cycle in analogy of the human body [1]. There-
fore it was our issue to develop a biomimetic 3D tissue
culture with an artificial but functional blood vessel sys-
tem. It should generate a biocompatible and complex
three-dimensional microenvironment that supports the
growth of tissue cells. A possibility to realise a biofunc-
tional vascular system is the integration of several hollow
fibres into the cell carrier [2]. They have to be integrated
and connected to a dynamic micro-bioreactor system to
ensure the supply of the artificial tissue with oxygen and
nutrient. The main challenge of this study was the connec-
tion between the biological and technological system [1].
2 Methods
2.1 Perfusion micro-bioreactor system
The bioreactor system is based on the established Multi-
Organ-Chip platform, developed in cooperation between
Fraunhofer IWS and the Institute of Biotechnology of
Technical University of Berlin. This platform is shown in
Image 1.
Image 1 Multi-Organ-Chip on microscope
The flow is pneumatically realised and is regulated by an
automatic control module. The fluidic parameters can be
adjusted by the software system.
With this system it is possible to cultivate different kinds
of tissues simultaneously due to the integration of different
cell culture chambers, fluidic reservoirs, valve inlets and
micro-actors like an automatic pneumatic pump system
(Image 2). Over a closed flow circuit that rebuilds a micro-
environment the cells can interact with each other [1].
Currently, it includes several replaceable cell inserts for
cultivation. But due to large diffusions paths it is difficult
to ensure the supply of oxygen and nutrient despite the
utilisation of a perfusion system.
A solution for the limitation might be the integration of a
hollow fibres system.
Biomed Tech 2012; 57 (Suppl. 1) © 2012 by Walter de Gruyter · Berlin · Boston. DOI 10.1515/bmt-2012-4213
982
Bereitgestellt von | Technische Universität Berlin
Angemeldet
Heruntergeladen am | 26.10.17 10:07
Image 2 Schematic representation of the layout of a self
contained Multi-Organ-Chip
2.2 3D Scaffold Printer
The 3D Scaffold Printer (Image 3) is an innovative tool
for creation of open porous cell carriers and scaffolds.
The device consists of a 3 channel dispensing module,
flexible PC software and a high-precision XYZ robotic
with a travel range in A3 size. It is possible to structure
media variety of biological (biopolymer) or synthetic
pasty materials into thin strands [3].
Repeating this strands and arranging them during the
process allows the creation of individual porous systems
as cell carrier for the three-dimensional cell cultivation.
Up to three different components can be dispensed. An
accurate XY offset compensation is given by individual
lowering of each cartridge. The exact trajectory of each
cartridge is monitored by a sensor system.
Image 3 3D Scaffold Printer
The 3D Scaffold Printer was developed by the company
GeSiM mbH (Großerkmannsdorf) and the dosing module
is an in-house development by Fraunhofer IWS.
2.3 Material
In cooperation with the Centre for Translational Bone,
Joint and Soft Tissue Research of TU Dresden an applica-
tion-specific cell-matrix-composite based on alginate hy-
drogels was developed. To cross-link the material an
aqueous solution of calcium chloride was applied. Pre-
liminary tests have shown the suitability of this material
combination. Using pre-sterilised materials and working
under sterile conditions allows the simultaneous embed-
ding of living cells during scaffold production.
3 Results
3.1 Adjusted perfusion micro-bioreactor
system
For integration of the hollow fibres into the micro perfu-
sion bioreactor the cell culture system had to be adjusted to
the new requirements.
Image 4 Schematic representation of the adjusted fluidic
system
For first experiments the fluidic system has been equipped
with only one cell culture chamber (Image 4). Its structure
was modified to include the hollow fibres. Additionally,
the design of the fluidic channels must be specifically en-
gineered to enable the circulation of cell culture media
through the whole system.
Biomed Tech 2012; 57 (Suppl. 1) © 2012 by Walter de Gruyter · Berlin · Boston. DOI 10.1515/bmt-2012-4213
983
Bereitgestellt von | Technische Universität Berlin
Angemeldet
Heruntergeladen am | 26.10.17 10:07
The first version of the adjusted perfusion micro-bioreactor
system was manufactured successfully (Image 5).
Image 5 Adjusted perfusion micro-bioreactor system
3.2 Adjusting of the 3D Scaffold Printer
dosing module
By using the 3D Scaffold Printer technology it should
also be possible to create hollow fibres. For this it was
necessary to adjust the dosing module to the new re-
quirements. (Image 6)
Image 6 Dosing module of the 3D Scaffold Printer
Therefore two cartridges were connected with each other
over an engineered dispensing needle system to enable a
dual extrusion. One of the needles is fixed inside the other
and acts as spacer and has to be exactly aligned for the
creation of hollow fibres. Therefore both needles defined
the inside and outside diameter of the structure according
to the printing materials.
Image 7 Schematic representation of the adjusted dosing
module
In a printing process (Image 7) the first cartridge is filled
with cell carrier material (e. g. a biopolymer paste) which
is extruded by applying a defined pressure. The other car-
tridge is containing a cross linking agent to cure the cell
carrier medium. Since both printing materials usually
have different viscosities and therefore different rheologi-
cal properties, the dosing module was redesigned to gen-
erate different pressures in one printing process. More-
over, by using media with a low viscosity it is necessary
to attach a negative pressure on the cartridges to prevent
uncontrolled leakage of the media. The regulation of
switching between pressure and vacuum has to be ar-
ranged by the control module. Additionally, both car-
tridges are controlled in parallel to the dosing process and
the trajectory over this module to ensure a continuous
structure production.
Biomed Tech 2012; 57 (Suppl. 1) © 2012 by Walter de Gruyter · Berlin · Boston. DOI 10.1515/bmt-2012-4213
984
Bereitgestellt von | Technische Universität Berlin
Angemeldet
Heruntergeladen am | 26.10.17 10:07
3.3 Plotted hollow fibres
In response to the adjustment of the dosing module the
first hollow fibres based on the alginate cell-matrix-
composite could be produced successfully by using the 3D
Scaffold Printer technology (Image 8 and 9).
Image 8 Cross section of a plotted hollow fibre
Image 9 Top view of plotted hollow fibres
First produced hollow fibres could be realised with a
minimal outside diameter of ca. 720 µm and an inside di-
ameter of ca. 250 µm by using a dosing needle with an in-
side diameter of 840 µm and an integrated thorn with an
outside diameter of 520 µm.
The produced hollow fibres could also be successfully
integrated into the newly developed bioreactor system.
4 Conclusion
With the novel technology platform a new powerful tool
for research and development in the area of tissue engi-
neering, drug screening and cytotoxicity tests will be
available.
The next item is the assessment of the suitability and
steadiness of the hollow fibres during perfused cell culture
conditions. Moreover, studies will be continued related to
flow behaviour and diffusion properties as a function of
pressure applied to the fluidic system. To expand the ap-
plicability of the system the results shall also be transferred
to other biopolymers.
Acknowledgements
The authors gratefully acknowledge the financial support
by the European Union, the Federal State of Saxony and
the ESF (European Social Fond).
5 References
[1] Sonntag, F., Gruchow, M., Wagner, I., Lindner, G.,
Marx, U.: Miniaturisierte humane organtypische Zell-
und Gewebekulturen. BIOspektrum 2011
[2] Meyer, W., Engelhardt, S., Novosel, E., Elling, B.,
Wegener, M., Krüger, H.: Soft Polymers for Building
up Small and Smallest Blood Supplying Systems by
Stereolithography. J. Funct. Biomater. 2012, 3, 257-
268
[3] A. Lode, K. Meißner, Y. Luo, F. Sonntag, S. Glorius,
B. Nies, C. Vater, F. Despang, Th. Hanke, M. Ge-
linsky: Fabrication of porous scaffolds with defined
inner and outer morphology by 3D plotting of a pasty
calcium phosphate bone cement. J. Tissue Eng. Reg.
Med. 2012 (accepted)
Biomed Tech 2012; 57 (Suppl. 1) © 2012 by Walter de Gruyter · Berlin · Boston. DOI 10.1515/bmt-2012-4213
985
Bereitgestellt von | Technische Universität Berlin
Angemeldet
Heruntergeladen am | 26.10.17 10:07